TRIP6 is a RIP2-associated common signaling component of multiple NF-κB activation pathways
Lianyun Li(Wuhan University), Hong‐Bing Shu(Wuhan University), Danying Chen(Institut polytechnique de Grenoble), Lianghua Bin(Central South University), Fu Li(Chinese Academy of Sciences), Yi Liu(Ningbo University), Zhonghe Zhai(Scripps Research Institute)
Cited by 59
Related Papers
ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization
|Proceedings of the National Academy of Sciences|2009|864
Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
|Journal of Experimental & Clinical Cancer Research|2017|656
SIKE is an IKKε/TBK1‐associated suppressor of TLR3‐ and virus‐triggered IRF‐3 activation pathways
|The EMBO Journal|2005|157
TRIM38 inhibits TNFα- and IL-1β–triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3
|Proceedings of the National Academy of Sciences|2014|151